Senators Launch Inquiry Into Sovaldi’s Pricing

by Admin | July 11, 2014 3:17 pm

July 11, 2014—The Senate Finance Committee’s Democratic chairman and a senior Republican member want Gilead Sciences to justify the $1,000-a-day price of its hepatitis C virus drug Sovaldi. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/07/senators-launch-inquiry-into-sovaldis-pricing/

Copyright ©2025 340binformed.org unless otherwise noted.